Table 3

Algorithm of diagnosing early MF developed by the ISCL

Criteria
Scoring system
BasicAdditionalOther2 points1 point
Clinical Persistent and/or progressive patches/thin plaques (1) Non–sun-exposed location  2 points for basic criteria and 2 additional criteria 1 point for basic criteria and 1 additional criteria 
  (2) Size/shape variation    
  (3) Poikiloderma    
Histopathologic Superficial lymphoid infiltrate (1) Epidermotropism without spongiosis  2 points for basic criteria and 2 additional criteria 1 point for basic criteria and 1 additional criteria 
  (2) Lymphoid atypia*    
Molecular biologic   Clonal T-cell receptor gene rearrangement  1 point for clonality 
Immunopathologic   < 50% CD2+, CD3+, and/or CD5+ cells  1 point for 1 or more criteria 
   < 10% CD7+ cells   
   Epidermal/dermal discordance of CD2, CD3, CD5, or CD7   
Criteria
Scoring system
BasicAdditionalOther2 points1 point
Clinical Persistent and/or progressive patches/thin plaques (1) Non–sun-exposed location  2 points for basic criteria and 2 additional criteria 1 point for basic criteria and 1 additional criteria 
  (2) Size/shape variation    
  (3) Poikiloderma    
Histopathologic Superficial lymphoid infiltrate (1) Epidermotropism without spongiosis  2 points for basic criteria and 2 additional criteria 1 point for basic criteria and 1 additional criteria 
  (2) Lymphoid atypia*    
Molecular biologic   Clonal T-cell receptor gene rearrangement  1 point for clonality 
Immunopathologic   < 50% CD2+, CD3+, and/or CD5+ cells  1 point for 1 or more criteria 
   < 10% CD7+ cells   
   Epidermal/dermal discordance of CD2, CD3, CD5, or CD7   

A total of 4 points is required for the diagnosis of MF based on any combination of points from the clinical, histopathologic, molecular biologic, and immunopathologic criteria.

*

Lymphoid atypical is defined as cells with enlarged hyperchromatic nuclei and irregular or cerebriform nuclear contours.

T-cell antigen deficiency confined to the epidermis.